Unanswered questions - Drug-eluting stents and the risk of late thrombosis

[1] [Anonymous], CYPH SIR EL COR STEN

[2] [Anonymous], TAX EXPR 2 PACL EL C

[3] *FDA, 2007, FDA STAT COR DRUG EL

[4] Food and Drug Administration, 2006, CIRC SYST DEV ADV PA

[5] ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) [J]. CIRCULATION, 2006, 113 (01) : 156 - 175

[1] [Anonymous], CYPH SIR EL COR STEN

[2] [Anonymous], TAX EXPR 2 PACL EL C

[3] *FDA, 2007, FDA STAT COR DRUG EL

[4] Food and Drug Administration, 2006, CIRC SYST DEV ADV PA

[5] ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) [J]. CIRCULATION, 2006, 113 (01) : 156 - 175